|

ANS03 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Avistone Biotechnology Co., Ltd.1

Indications

  • Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration1
  • Cancer1

New York, New York1 trial

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.